Nektar Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results
Go back to Nektar Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 67.25 +1.55 (2.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.70 | 52 Week High | $19.98 | |||
| Open | $64.10 | 52 Week Low | $10.52 | |||
| Day High | $67.25 | P/E | N/A | |||
| Day Low | $64.10 | EPS | $-1.45 | |||
| Volume | 331,009 | |||||
